Product Name :
Linagliptin
Description:
Linagliptin, also known as BI-1356, is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.
CAS:
668270-12-0
Molecular Weight:
472.54
Formula:
C25H28N8O2
Chemical Name:
8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Smiles :
CN1C2N=C(N(CC#CC)C=2C(=O)N(CC2=NC3=CC=CC=C3C(C)=N2)C1=O)N1C[C@H](N)CCC1
InChiKey:
LTXREWYXXSTFRX-QGZVFWFLSA-N
InChi :
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Linagliptin, also known as BI-1356, is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.{{Atovaquone} MedChemExpress|{Atovaquone} Cytochrome P450|{Atovaquone} Technical Information|{Atovaquone} Formula|{Atovaquone} supplier|{Atovaquone} Epigenetic Reader Domain} Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes.{{OF-1} site|{OF-1} Epigenetics|{OF-1} Biological Activity|{OF-1} Purity|{OF-1} custom synthesis|{OF-1} Autophagy} It is being marketed by Boehringer Ingelheim and Lilly.PMID:36628218 |Product information|CAS Number: 668270-12-0|Molecular Weight: 472.54|Formula: C25H28N8O2|Chemical Name: 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione|Smiles: CN1C2N=C(N(CC#CC)C=2C(=O)N(CC2=NC3=CC=CC=C3C(C)=N2)C1=O)N1C[C@H](N)CCC1|InChiKey: LTXREWYXXSTFRX-QGZVFWFLSA-N|InChi: InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|
